← Open Payments lookup

CAROLYN GREELY: Open Payments

NPI 1104442326 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$189 in 9 payments from 6 companies in 2025. Trend: 2023 $573 · 2024 $801 · 2025 $189

Food & beverage: $189
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$59
Novartis Pharmaceuticals Corporation2$42
Boehringer Ingelheim Pharmaceuticals, Inc.1$30
Alnylam Pharmaceuticals Inc.1$24
E.R. Squibb & Sons, L.L.C.1$20
Bayer Healthcare Pharmaceuticals Inc.1$14

Products named: FARXIGA, LEQVIO, JARDIANCE, ELIQUIS, Kerendia.

Industry payments across MD — which companies pay providers there.